Dr. Reddy's Laboratories Limited DRREDDY

Latest filings

• Routine15 22 Sept, 17:00 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• Board meeting40 22 Sept, 16:58 · BSE
  Dr Reddys Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Standalone ....
• Routine15 21 Sept, 16:50 · NSE
  Schedule of meet
• General25 18 Sept, 09:04 · NSE
  Has today, i.e., September 18, 2026, entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India Private Limited for Qdenga® in the private market in India.
• General25 18 Sept, 09:00 · BSE
  Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
• Routine15 18 Sept, 08:46 · NSE
  Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s gets voluntary licence for Gilead s once-yearly HIV prevention drug
• General25 18 Sept, 08:41 · BSE
  Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
• Routine15 17 Sept, 15:57 · NSE
  Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s gets voluntary licence for Gilead s once-yearly HIV prevention drug
• Routine15 16 Sept, 22:10 · NSE
  Copy of Newspaper Publication
• General25 11 Sept, 22:08 · NSE
  General Updates

Shown 15 minutes after publication. Real time with Pro.